Biocon Limited
BIOCON
주식 순위
#3391
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
주가
$3.76
시가총액
$5.14B
변동 (1일)
-2.11%
변동 (1년)
-7.08%
국가
IN
거래 Biocon Limited (BIOCON)
카테고리
Healthcare
Biocon Limited (BIOCON)의 배당 수익률 기록
Biocon Limited (주식 심볼: BIOCON)의 배당 수익률 (TTM)은 2024-03-31 기준으로 0.63%입니다.
지난 5년 평균 배당 수익률: 0.22%
지난 5년 평균 배당 수익률: 0.22%
Biocon Limited (BIOCON)의 배당 수익률 기록: 2004 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
| 연도 | 배당 수익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 0.14% | -30.00% |
| 2025 | 0.20% | -68.25% |
| 2024 | 0.63% | 117.24% |
| 2023 | 0.29% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | 0.22% | 0.00% |
| 2019 | 0.22% | 0.00% |
| 2018 | 0.22% | 0.00% |
| 2017 | 0.00% | -100.00% |
| 2016 | 2.22% | 73.44% |
| 2015 | 1.28% | -28.89% |
| 2014 | 1.80% | 1.12% |
| 2013 | 1.78% | -7.29% |
| 2012 | 1.92% | 84.62% |
| 2011 | 1.04% | -3.70% |
| 2010 | 1.08% | -40.33% |
| 2009 | 1.81% | 151.39% |
| 2008 | 0.72% | 35.85% |
| 2007 | 0.53% | 12.77% |
| 2006 | 0.47% | 88.00% |
| 2005 | 0.25% | 0.00% |
| 2004 | 0.00% | 0.00% |
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
| 회사 | 배당 수익률 | 국가 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
